tyme technologies stock forum

Tyme Technologies Inc a biotechnology company develops cancer metabolism-based therapies CMBTs in the United States. Tyme Technologies TYME stock price charts trades the USs most popular discussion forums.

Tyme Technologies Inc Tyme Stock Message Board Investorshub

Its lead candidate is the SM-88 a CMBT that is in a Phase IIIII clinical trial to treat across 15 types of cancer including pancreatic lung breast prostate sarcoma and lymphoma.

. Largest shareholders include Vanguard Group Inc VTSMX - Vanguard Total Stock Market Index. Tyme Technologies Inc USTYME has 94 institutional owners and shareholders that have filed 13DG or 13F forms with the Securities Exchange Commission SEC. These institutions hold a total of 16151006 shares.

Its lead candidate is the SM-88 a CMBT that is in a Phase IIIII clinical trial to treat across 15 types of cancer including pancreatic lung breast prostate sarcoma and lymphoma. The small-cap sell-off has pushed the share price. Tyme Technologies stock was trading at 105 on March 11th 2020 when Coronavirus COVID-19 reached pandemic status according to the World Health Organization WHO.

The Companys lead clinical CMBT compound SM-88 is an oral investigational modified tyrosine derivative that is hypothesized to interrupt the metabolic. The reporting person undertakes to provide to Tyme Technologies Inc any security holder of Tyme Technologies Inc or the staff of the Securities and Exchange Commission upon request full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. TYME Stock Message Board for Investors.

Is a biotechnology company. After each calculation the program assigns a buy sell or hold value for each study. Stock Price News and Company Updates.

Friday June 11 2021 Futures UpDown Last Dow 7500 022 34429 SP 500 425 011 4233 Nasdaq 1350 009 13963 Stock futures are looking higher trying to build off yesterdays gains as the SP 500 Index posted its first closing high in over a month and as the Nasdaq Composite outperformed rising over 075 as the yield on the benchmark 10-year. Tyme Technologies NASDAQTYME Analyst Ratings Frequently Asked Questions Do MarketBeat users like Tyme Technologies more than its competitors. Tyme Technologies Inc TYME USD00001 Hargreaves Lansdown 2182022 TYME Technologies Inc.

Our comprehensive analysis of fundamental and technical factors gives TYME a rank of 4. TYME Tyme Technologies Inc Stock Price and Discussion Stocktwits. During the day the stock fluctuated 937 from a day low at 030 to a day high of 033.

Free forex prices toplists indices and lots more. View which stocks have been most impacted by COVID-19. The Company is focused on developing cancer metabolism-based therapies CMBTs for a range of solid tumors and hematologic cancers.

Share your opinion and gain insight from other stock traders and investors. Our methodology considers analysis of the companys financial situation and how it has traded recently. SM 88 its proprietary drug candidate compound is a novel compound that has the.

Tyme Technologies Inc NASDAQ Updated Mar 18 2022 1157 PM. Institutional Ownership and Shareholders. A high-level overview of Tyme Technologies Inc.

Tyme Technologies Inc is the US based clinical-stage biotechnology company. Find the latest Tyme Technologies Inc. And has now gained 3 days in a rowIt will be exciting to see whether it manages to continue gaining or take a minor break for the next few days.

MarketBeat users like Tyme Technologies stock less than the stock of other Medical companies. Announces SM-88 Poster at the American Association for Cancer Research AACR Annual Meeting 2022. Tyme Technologies Inc a biotechnology company develops cancer metabolism-based therapies CMBTs in the United States.

Barchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. 6558 of MarketBeat users gave Tyme Technologies an outperform vote while medical companies recieve an. TYME stock quote history news and other vital information to help you with your stock trading and investing.

Since then TYME stock has decreased by 684 and is now trading at 03320. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. Find the latest Tyme Technologies Inc.

Tyme Technologies TYME gets a very poor rank from InvestorsObserver. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Medical - Drugs Total Posts.

TYME Stock Analysis Overview. The Tyme Technologies Inc stock price gained 1056 on the last trading day Thursday 17th Mar 2022 rising from 029 to 033. Ad 1000 Strong Buy Stocks that Double the SP.

Message Board Total Posts. Forcasts revenue earnings analysts expectations ratios for TYME TECHNOLOGIES INC. Tyme Technologies Inc Stock Symbol.

The Opinions takes up to 5 years worth of historical data and runs these prices through thirteen different technical indicators. TYME 033 001 197 Post-Market 000 060 12091. Stock TYME US90238J1034.

Tyme Technologies recently reported their Q2 earnings that revealed the company only burned roughly 5M in cash with about 97M left in the bank. TYME stock discussion in Yahoo Finances forum.

Tyme Technologies Inc Tyme Stock Forums Investing Com